Clinical Trials Browser

Pleural Effusion, Malignant

NCT07274813 2026-03-03

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

254 enrolled

Other solid neoplasmThoracic

Advanced/Metastatic Solid Tumors

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

30 enrolled

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07235280 2026-02-19

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Phase EARLY_PHASE1 Recruiting

48 enrolled

Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT05493566 2026-02-12

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase EARLY_PHASE1 Recruiting

15 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05620342 2026-02-05

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Phase EARLY_PHASE1 Recruiting

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07236177 2026-02-05

B-GLUCANCER2

Phase EARLY_PHASE1 Recruiting

220 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06639191 2026-01-30

AKIR001

Phase EARLY_PHASE1 Recruiting

15 enrolled

EndocrineGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Vulvar Neoplasms, Thyroid Carcinoma, Anaplastic

NCT06653023 2026-01-20

Wondercel-UWD3

Phase EARLY_PHASE1 Recruiting

60 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT06928922 2026-01-13

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

Phase EARLY_PHASE1 Recruiting

83 enrolled

Thoracic

Advanced Lung Cancer

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

32 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Phase EARLY_PHASE1 Recruiting

24 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06712745 2025-11-10

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

Phase EARLY_PHASE1 Recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

NCT04684459 2024-10-30

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Phase EARLY_PHASE1 Recruiting

18 enrolled

Thoracic

Pleural Effusion, Malignant

NCT05543954 2024-07-05

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Phase EARLY_PHASE1 Recruiting

60 enrolled

Thoracic

Lung Neoplasms

NCT05060796 2024-06-25

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

Phase EARLY_PHASE1 Recruiting

11 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05341492 2024-06-25

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

Phase EARLY_PHASE1 Recruiting

30 enrolled

BreastThoracic

EGFR/ B7H3-positive Advanced Lung Cancer

NCT06436885 2024-05-31

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

Phase EARLY_PHASE1 Recruiting

39 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06329908 2024-03-26

DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Phase EARLY_PHASE1 Recruiting

20 enrolled

Thoracic

Lung Neoplasms

NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

20 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

Clinical Trials

Safety and Efficacy of NK510 to Treat NSCLC

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

B-GLUCANCER2

AKIR001

Wondercel-UWD3

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

VARTUTRACE

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors